Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Completed 5Active not recruiting 3Recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 5Carcinoma in Situ 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Mastectomy, Subcutaneous × Clear all
NCT02311959 2026-04-14

MAPAM-01

Institut Claudius Regaud

Phase 3 Completed
450 enrolled
Breast

Breast Neoplasms, Carcinoma in Situ

NCT02891759 2023-05-06

Compare Outcomes Between Two Acellular Dermal Matrices

Washington University School of Medicine

Phase 2 Completed
320 enrolled
Breast

Breast Neoplasms

NCT01002014 2022-04-21

Nipple Sparing Mastectomy - Cosmetic Outcomes

Wake Forest University Health Sciences

Phase NA Completed
75 enrolled
Breast

Breast Neoplasms

NCT04640454 2020-11-23

Assessment of Nipple Sparing Mastectomy as a Treatment Option for Breast Cancer

Alexandria University

Completed
35 enrolled
Breast

Breast Neoplasms

NCT02061527 2018-04-24

Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer Treatment

Karolinska University Hospital

Phase NA Completed
135 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡